BCAX vs GCT
Comparison between Bicara Therapeutics Inc (BCAX, Company) and GigaCloud Technology Inc - Class A (GCT, Company).
BCAX is from the Healthcare sector, while GCT is from the Technology sector.
BCAX vs GCT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
BCAX
$1.70B
GCT
$1.70B
Max Drawdown
Winner
BCAX
67.82%
GCT
91.11%
Sharpe Ratio
Winner
BCAX
1.89
GCT
1.45
5Y Beta
Winner
BCAX
1.38
GCT
1.74
Industry
BCAX
Biotechnology
GCT
Software - Infrastructure
P/E Ratio
Winner
BCAX
-9.64
GCT
12.79
Forward P/E
BCAX
N/A
GCT
10.47
PEG Ratio
BCAX
N/A
GCT
1.31
Debt to Equity
BCAX
0.00%
GCT
0.00%
Free Cash Flow Yield
BCAX
-6.87%
Winner
GCT
8.82%
P/S Ratio
BCAX
N/A
GCT
1.25
P/B Ratio
BCAX
3.46
Winner
GCT
3.20
BCAX vs GCT - Historical Returns
Returns include dividend reinvestment.
1M
BCAX
-7.70%
Winner
GCT
+58.06%
3M
BCAX
+21.52%
Winner
GCT
+24.30%
6M
Winner
BCAX
+82.68%
GCT
+32.30%
1Y
Winner
BCAX
+175.10%
GCT
+140.41%
Max(CAGR)
BCAX
+10.02%
Winner
GCT
+36.04%
BCAX vs GCT - Annual Returns (2022 - 2026)
Returns include dividend reinvestment.
| Year | BCAX | GCT |
|---|---|---|
| 2026 | +71.31% | +37.38% |
| 2025 | -0.56% | +106.09% |
| 2024 | -25.59% | -7.68% |
| 2023 | N/A | +234.46% |
| 2022 | N/A | -63.73% |
BCAX vs GCT Drawdown Comparison
The maximum drawdown for BCAX was -67.82%, occurring on Jun 27, 2025. Recovery took 445 trading sessions.
The maximum drawdown for GCT was -91.11%, occurring on Nov 2, 2022. Recovery took 916 trading sessions.
The current BCAX drawdown is -7.70%.
| Rank | BCAX | GCT |
|---|---|---|
| #1 | -67.82% Sep 17, 2024 - Jun 29, 2026 | -91.11% Aug 19, 2022 - Apr 16, 2026 |
| #2 | -15.33% Jul 7, 2026 - Aug 3, 2026 | -39.13% Apr 17, 2026 - Aug 6, 2026 |
| #3 | -2.63% Jun 30, 2026 - Jul 7, 2026 | N/A |
Correlation
Correlation between BCAX and GCT is 0.56 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.56
-101
Select Stocks to Compare
Popular: BCAX vs SPYGCT vs SPY
More Comparisons
Compare with similar stocks